The long road to diagnosis, from gastroesophageal reflux disease, through Barrett's esophagus, to visceral hypersensitivity: a case report
Abstract
Background: Visceral hypersensitivity syndrome is a condition involving excessive perception of mechanical stimuli in the intestines. In patients suffering from this disorder, physiological bowel function causes pain and discomfort.
Case summary: The patient presented is a 26-year-old man with severe gastrointestinal symptoms that were difficult to manage, such as heartburn, pressure in the esophageal region, a sensation of a gullet in the throat, food retention, and frequent belching. The man had been experiencing these symptoms intermittently for four years, during which time he had been treated without success. By way of exclusion, a diagnosis of visceral hypersensitivity was made, and a low dose of amitriptyline was administered. Psychological therapy was also recommended. This treatment brought significant improvement and resulted in the resolution of his complaints.
Conclusions: Visceral hypersensitivity is strongly associated with psychosocial factors, which should be taken into account when treating patients with gastrointestinal disorders. Low doses of amitriptyline may be an effective treatment option.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.